Roche completes takeover of Flatiron Health

Roche has announced the completion of its previously announced takeover of the New York-based healthcare technology and services company Flatiron Health.

The $1.9 billion (GBP 1.36 billion) deal gives Roche control over a leading developer of oncology-specific electronic health record software, with the company also specialising in the curation and development of real-world evidence for cancer research.

Flatiron Health operates a large network of community oncology practices and academic medical centres, supported by a technology platform designed to learn from the personal experience of every patient.

Following the conclusion of this deal, Flatiron Health will continue its operations as a separate legal entity, with its current business model, network of partnerships and overall objectives remaining the same.

Daniel O'Day, chief executive officer of Roche Pharmaceuticals, said: "This is an important step in our personalised healthcare strategy for Roche, as we believe that regulatory-grade real-world evidence is a key ingredient to accelerate the development of, and access to, new cancer treatments."

With over 20 years of experience within the pharmaceutical market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current pharmaceutical roles we have available, you can search for the latest job roles, register your details, or contact the team today.